Type 2 diabetes mellitus: a disease of the innate immune system? An update.
about
p38 Mitogen-activated protein kinase plays a stimulatory role in hepatic gluconeogenesis.The clinical applications of a systems approach.Serum C-reactive protein concentration and measures of adiposity in patients with type 2 diabetes mellitus.Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortality.Inflammatory cytokines in diabetic nephropathy.Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus.Pentoxifylline reduces the inflammatory process in diabetic rats: relationship with decreases of pro-inflammatory cytokines and inducible nitric oxide synthaseMarkers of Oxidative Stress in Pregnant Women with Sleep DisturbancesAssociation between Toll-Like Receptor 4 and Occurrence of Type 2 Diabetes Mellitus Susceptible to Pulmonary Tuberculosis in Northeast China.Psychoneuroimmune implications of type 2 diabetes: reduxAntioxidative and Anti-Inflammatory Activities of Galloyl Derivatives and Antidiabetic Activities of Acer ginnala.Type 2 diabetes, PUFAs, and vitamin D: their relation to inflammation.HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation.Role of mindin in diabetic nephropathy.Glucose metabolism in critically ill patients: are incretins an important player?Pathway analysis of coronary atherosclerosis.MicroRNA-29b inhibits diabetic nephropathy in db/db mice.Vitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism.Systemic inflammatory responses in patients with type 2 diabetes with chronic periodontitis.Group B streptococcus infections of soft tissue and bone in California adults, 1995-2012.Effects of metformin on blood and urine pro-inflammatory mediators in patients with type 2 diabetes.White blood cell count and cardiovascular biomarkers of atherosclerosis.Glomerular proliferation during early stages of diabetic nephropathy is associated with local increase of sphingosine-1-phosphate levels.Association of toll-like receptor 4 polymorphisms with type 2 diabetes mellitus.The effects of C-glycosylation of luteolin on its antioxidant, anti-Alzheimer's disease, anti-diabetic, and anti-inflammatory activities.Effects of vaspin on pancreatic β cell secretion via PI3K/Akt and NF-κB signaling pathways.The value of visfatin in the prediction of metabolic syndrome: a multi-factorial analysis.Common promoter polymorphism in monocyte differentiation antigen CD14 is associated with serum triglyceride levels and body mass index in non-diabetic individuals.Diabetes Mellitus and Liver Surgery: The Effect of Diabetes on Oxidative Stress and Inflammation.CD40-mediated HIF-1α expression underlying microangiopathy in diabetic nerve pathology.Use of Readily Accessible Inflammatory Markers to Predict Diabetic Kidney Disease.Adipokines and inflammatory markers in elderly subjects with high risk of type 2 diabetes and cardiovascular disease
P2860
Q33226681-B27304DC-008F-4298-B16E-7BF32A4E2DCCQ33242858-90CA157B-B76A-4D1B-B5BF-AB80A2064590Q33307194-2AB84C21-BB8F-4C54-8199-E0EE35E34D9CQ33565593-6CD8C36B-D3E7-4F25-8DC4-C1D83FB05E92Q35133177-AD3953BA-D594-43B5-B4F3-7217EF6EFD9BQ35145862-6507A00C-C8FA-4525-82FE-0C286993CF3FQ35544336-9EFADFCB-0156-4E6A-ABCB-6B46B33D4CB1Q36033000-779F8986-555A-42E4-9908-E1BF307E88DFQ36795548-E62797AD-05F5-44EC-A998-B38B4A1F1EF5Q37336959-6C0B4208-AC48-451E-84B0-363ABB653C07Q37703459-046772AE-F001-4755-A735-126EBD57728BQ37704860-38BF328F-C747-4F6C-8153-A37F0606AC06Q37876420-D7FF1A38-FEDB-4DEC-A44E-029DF3BE3E51Q37974895-4DE2FB5B-2B5F-4237-9B36-025CD5255DE1Q38142955-4FB9B31E-88FE-491B-9883-A84D3556CD99Q38520286-614B7E36-3F05-4B8A-9F82-D1B4B24FE7DEQ38692630-B9FD1D26-5D4D-42FE-A10E-6079A7B3C092Q39242378-931F4BD7-DDB4-4332-963A-2624A0D770CCQ39367870-AABB48F0-36A2-4C0C-8557-3B0767A875AAQ40486947-9E0660E1-DF05-48E2-8557-99B40D22BC6DQ42363819-3FCCF21A-9D4E-4807-89A4-9DF0335157E1Q43052757-B5D8B1FF-3C17-45E3-9D29-BD348A251FF0Q45264630-F3FACAB6-A517-4DA1-997B-43D60D262B96Q46498426-6ED15B19-94AA-4456-BB5E-024D933DFD1BQ46871367-F6FC39AA-814F-4107-8F0F-311D479F62D8Q47105684-B76C2F65-E94E-48BC-B494-BC785B354909Q51356778-AD63F390-86AA-4675-990A-CD614A152469Q53605921-65920709-A0FF-4B51-A273-DD74B6F056F5Q54939023-6844233F-9E61-4747-BFDF-E8100BDF52AFQ54982064-C1C29154-3304-4511-91B3-D5720F58AF7BQ55312504-2AF4BD2E-8E16-436E-81ED-34FCA14D36C6Q58707565-C5FFB8EF-5FB9-4816-A4C4-3A0ED72D2CF1
P2860
Type 2 diabetes mellitus: a disease of the innate immune system? An update.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Type 2 diabetes mellitus: a disease of the innate immune system? An update.
@ast
Type 2 diabetes mellitus: a disease of the innate immune system? An update.
@en
type
label
Type 2 diabetes mellitus: a disease of the innate immune system? An update.
@ast
Type 2 diabetes mellitus: a disease of the innate immune system? An update.
@en
prefLabel
Type 2 diabetes mellitus: a disease of the innate immune system? An update.
@ast
Type 2 diabetes mellitus: a disease of the innate immune system? An update.
@en
P1433
P1476
Type 2 diabetes mellitus: a disease of the innate immune system? An update.
@en
P2093
P304
P356
10.1046/J.1464-5491.2003.01030.X
P577
2004-03-01T00:00:00Z